JP2023522038A5 - - Google Patents
Info
- Publication number
- JP2023522038A5 JP2023522038A5 JP2022562711A JP2022562711A JP2023522038A5 JP 2023522038 A5 JP2023522038 A5 JP 2023522038A5 JP 2022562711 A JP2022562711 A JP 2022562711A JP 2022562711 A JP2022562711 A JP 2022562711A JP 2023522038 A5 JP2023522038 A5 JP 2023522038A5
- Authority
- JP
- Japan
- Prior art keywords
- hinge
- ccr
- item
- car
- hinge region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025106623A JP2025129196A (ja) | 2020-04-17 | 2025-06-24 | 修飾ccrポリペプチド及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011494P | 2020-04-17 | 2020-04-17 | |
| US63/011,494 | 2020-04-17 | ||
| PCT/US2021/027648 WO2021211948A1 (en) | 2020-04-17 | 2021-04-16 | Modified ccr polypeptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106623A Division JP2025129196A (ja) | 2020-04-17 | 2025-06-24 | 修飾ccrポリペプチド及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522038A JP2023522038A (ja) | 2023-05-26 |
| JP2023522038A5 true JP2023522038A5 (cg-RX-API-DMAC7.html) | 2024-04-25 |
| JP7802684B2 JP7802684B2 (ja) | 2026-01-20 |
Family
ID=78084154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562711A Active JP7802684B2 (ja) | 2020-04-17 | 2021-04-16 | 修飾ccrポリペプチド及びその使用 |
| JP2025106623A Pending JP2025129196A (ja) | 2020-04-17 | 2025-06-24 | 修飾ccrポリペプチド及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106623A Pending JP2025129196A (ja) | 2020-04-17 | 2025-06-24 | 修飾ccrポリペプチド及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240261404A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4136119A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7802684B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230005147A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115397864A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021255702A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180329A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021211948A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020379735A1 (en) | 2019-11-05 | 2022-05-26 | Regeneron Pharmaceuticals, Inc. | N-terminal SCFV multispecific binding molecules |
| WO2022094314A1 (en) * | 2020-10-30 | 2022-05-05 | The University Of North Carolina At Chapel Hill | Dual targeting chimeric antigen receptors |
| AU2023248532A1 (en) | 2022-04-08 | 2024-11-21 | Regeneron Pharmaceuticals, Inc. | Multipartite receptor and signaling complexes |
| EP4504768A2 (en) * | 2022-05-17 | 2025-02-12 | Arsenal Biosciences, Inc. | Systems of engineered receptors targeting psma and ca9 |
| USD1066799S1 (en) * | 2022-08-12 | 2025-03-11 | Kiss Nail Products, Inc. | Applicator for artificial eyelashes |
| TW202442689A (zh) | 2023-03-03 | 2024-11-01 | 美商亞森諾生物科學公司 | 靶向psma及ca9之系統 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5104853A (en) * | 1984-12-11 | 1992-04-14 | California Biotechnology Inc. | Alveolar surfactant proteins having cys to ser mutations |
| EP3115373B1 (en) * | 2010-09-08 | 2019-08-28 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Chimeric antigen receptors with an optimized hinge region |
| GB201513540D0 (en) * | 2015-07-31 | 2015-09-16 | King S College London | Therapeutic agents |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| AU2019315440B2 (en) * | 2018-07-30 | 2025-03-13 | Angeles Therapeutics, Inc. | Improving the efficacy and safety of adoptive cellular therapies |
| EP3632460A1 (en) * | 2018-10-05 | 2020-04-08 | St. Anna Kinderkrebsforschung | A group of chimeric antigen receptors (cars) |
| KR20210072797A (ko) * | 2018-10-05 | 2021-06-17 | 세인트 안나 킨더크렙스포르슝 | 키메라 항원 수용체(car) 그룹 |
| EP3632461A1 (en) * | 2018-10-05 | 2020-04-08 | St. Anna Kinderkrebsforschung | A group of chimeric antigen receptors (cars) |
| CN113474012B (zh) * | 2019-01-25 | 2023-09-08 | 湖南远泰生物技术有限公司 | Epcam抗体和epcam-car-t细胞 |
| MX2021015495A (es) * | 2019-06-14 | 2022-04-18 | 2Seventy Bio Inc | Composiciones y métodos para tratar cáncer. |
-
2021
- 2021-04-16 EP EP21789050.8A patent/EP4136119A4/en active Pending
- 2021-04-16 CN CN202180028302.8A patent/CN115397864A/zh active Pending
- 2021-04-16 AU AU2021255702A patent/AU2021255702A1/en active Pending
- 2021-04-16 KR KR1020227035279A patent/KR20230005147A/ko active Pending
- 2021-04-16 CA CA3180329A patent/CA3180329A1/en active Pending
- 2021-04-16 US US17/918,830 patent/US20240261404A1/en active Pending
- 2021-04-16 WO PCT/US2021/027648 patent/WO2021211948A1/en not_active Ceased
- 2021-04-16 JP JP2022562711A patent/JP7802684B2/ja active Active
-
2025
- 2025-06-24 JP JP2025106623A patent/JP2025129196A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7487112B2 (ja) | Cd19指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| AU2021307614B2 (en) | Engineered immune cell for allotransplantation | |
| JP7767502B2 (ja) | Nk阻害性分子を発現する遺伝子改変免疫細胞とその使用 | |
| JP2022537159A5 (cg-RX-API-DMAC7.html) | ||
| US20200038443A1 (en) | Multi-function and multi-targeting car system and methods for use thereof | |
| EP4219693A1 (en) | Chimeric antigen receptor targeting cd7 and use thereof | |
| CA3140393A1 (en) | Combinations of engineered natural killer cells and engineered t cells for immunotherapy | |
| JP2021514631A5 (cg-RX-API-DMAC7.html) | ||
| JP2020500530A5 (cg-RX-API-DMAC7.html) | ||
| JP2017504601A5 (cg-RX-API-DMAC7.html) | ||
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| JP2022513460A5 (cg-RX-API-DMAC7.html) | ||
| JP2015527070A5 (cg-RX-API-DMAC7.html) | ||
| CA3164666A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| JP2024534471A5 (cg-RX-API-DMAC7.html) | ||
| JP2024525727A5 (cg-RX-API-DMAC7.html) | ||
| WO2023207388A1 (zh) | 一种cd7基因被敲除的工程化免疫细胞及其用途 | |
| CN117187185A (zh) | 一种工程化免疫细胞及其用途 | |
| CN117004604A (zh) | 一种ciita基因被敲除的工程化免疫细胞及其用途 | |
| Weiner et al. | Antibodies and cancer therapy: versatile platforms for cancer immunotherapy | |
| JP2024531910A5 (cg-RX-API-DMAC7.html) | ||
| EP4663762A2 (en) | Immune rejection-resistant engineered cell | |
| US20210079111A1 (en) | Cd19-cd20 bispecific and dual passway car-t and methods for use thereof | |
| CN117430712A (zh) | 靶向cxcr6的嵌合抗原受体及其用途 |